The possible critical role of T-cell help in DSA-mediated graft loss.
Süsal, Caner; Slavcev, Antonij; Pham, Lien; Zeier, Martin; Morath, Christian.
; 31(6): 577-584, 2018 06.
Artigo em Inglês | MEDLINE | ID: mdl-29405445
Brentuximab vedotin, an antibody-drug conjugate, in patients with CD30-positive haematologic malignancies and hepatic or renal impairment.
Pre-existing donor-specific antibodies are detrimental to kidney allograft only when persistent after transplantation.
Pretransplant human leukocyte antigen antibodies detected by single-antigen bead assay are a risk factor for long-term kidney graft loss even in the absence of donor-specific antibodies.
T-Cell Surface Antigens and sCD30 as Biomarkers of the Risk of Rejection in Solid Organ Transplantation.
Minimum mycophenolic acid levels are associated with donor-specific antibody formation.
Association of early kidney allograft failure with preformed IgA antibodies to ß2-glycoprotein I.
De novo development of antibodies to kidney-associated self-antigens angiotensin II receptor type I, collagen IV, and fibronectin occurs at early time points after kidney transplantation in children.
Application of an epitope-based allocation system in pediatric kidney transplantation.
Seasonality of mortality and graft failure among kidney transplant recipients in the US - a retrospective study.
Immunizations for renal transplant candidates and recipients.